Premium intraocular lenses use in patients with cataract and concurrent glaucoma: a review
- PMID: 24371502
- PMCID: PMC3869122
Premium intraocular lenses use in patients with cataract and concurrent glaucoma: a review
Figures
Similar articles
-
Premium Intraocular Lenses in Glaucoma-A Systematic Review.Bioengineering (Basel). 2023 Aug 22;10(9):993. doi: 10.3390/bioengineering10090993. Bioengineering (Basel). 2023. PMID: 37760095 Free PMC article. Review.
-
Multifocal intraocular lenses in the setting of glaucoma.Curr Opin Ophthalmol. 2007 Feb;18(1):62-6. doi: 10.1097/ICU.0b013e328011d108. Curr Opin Ophthalmol. 2007. PMID: 17159450 Review.
-
Patient Utilization of Premium Intraocular Lenses Before and During the COVID-19 Pandemic.Eye Contact Lens. 2023 Jul 1;49(7):292-295. doi: 10.1097/ICL.0000000000001000. Epub 2023 May 11. Eye Contact Lens. 2023. PMID: 37167587
-
Descemet membrane endothelial keratoplasty combined with presbyopia-correcting and toric intraocular lenses - a narrative review.BMC Ophthalmol. 2023 Nov 25;23(1):483. doi: 10.1186/s12886-023-03240-5. BMC Ophthalmol. 2023. PMID: 38007433 Free PMC article. Review.
-
Premium intraocular lenses: The past, present and future.J Curr Ophthalmol. 2018 May 18;30(4):287-296. doi: 10.1016/j.joco.2018.04.003. eCollection 2018 Dec. J Curr Ophthalmol. 2018. PMID: 30555960 Free PMC article. Review.
Cited by
-
Effect of presbyopic correction lens on humphrey visual field testing in patients with multifocal intraocular lens.Medicine (Baltimore). 2023 Oct 13;102(41):e35544. doi: 10.1097/MD.0000000000035544. Medicine (Baltimore). 2023. PMID: 37832110 Free PMC article.
-
Premium Intraocular Lenses in Glaucoma-A Systematic Review.Bioengineering (Basel). 2023 Aug 22;10(9):993. doi: 10.3390/bioengineering10090993. Bioengineering (Basel). 2023. PMID: 37760095 Free PMC article. Review.
References
-
- Ellant JP, Obstbaum SA. Lens-induced glaucoma. Documenta Ophthalmologica. 1992;81:317–338. - PubMed
-
- Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–13. Discussion 829-30. - PubMed
-
- Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–79. - PubMed
-
- AGIS (Advanced Glaucoma Intervention Study) Investigators. The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy. Arch Ophthalmol. 2001;119:1771–9. - PubMed
-
- Casson RJ, Salmon JF. Combined surgery in the treatment of patients with cataract and primary open-angle glaucoma. J Cataract Refract Surg. 2001;27:1854–63. - PubMed
Publication types
LinkOut - more resources
Full Text Sources